Thrombocytapheresis in Patient with Essential Thrombocythemia: A Case Report.

Authors :: Elhassan AM
Alsaud A
Yassin MA
Aldapt M
Riaz L
Ghori F
Bin Ahmad A
Abdulla M
Source :: Case reports in oncology [Case Rep Oncol] 2020 Jun 16; Vol. 13 (2), pp. 675-679. Date of Electronic Publication: 2020 Jun 16 (Print Publication: 2020).
Publication Year :: 2020
Abstract: Essential thrombocythemia (ET) is one of the myeloproliferative neoplasms, characterized by persistent thrombocytosis, platelets >450,000/μL, and evident clonal abnormalities like JAK2 V617F, MPL, CALR mutation and not fulfilling WHO criteria for MDS, CML, PV, and IDA. Here we report a 24-year-old female who presented with headache and was found to have thrombocytosis with a platelet count of 2,141 × 10 <superscript>3</superscript> /μL, diagnosed as ET as per WHO criteria 2008; she required ICU admission and thrombocytapheresis with a favorable outcome.<br />Competing Interests: The authors have no conflicts of interest to declare.<br /> (Copyright © 2020 by S. Karger AG, Basel.)